Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

The New England Journal of Medicine
L BartalenaA Pinchera

Abstract

The chief clinical characteristics of Graves' disease are hyperthyroidism and ophthalmopathy. The relation between the two and the effect of treatment for hyperthyroidism on ophthalmopathy are unclear. We studied 443 patients with Graves' hyperthyroidism and slight or no ophthalmopathy who were randomly assigned to receive radioiodine, radioiodine followed by a 3-month course of prednisone, or methimazole for 18 months. The patients were evaluated for changes in the function and appearance of the thyroid and progression of ophthalmopathy at intervals of 1 to 2 months for 12 months. Hypothyroidism and persistent nyperthyroiaism were promptly corrected. Among the 150 patients treated with radioiodine, ophthalmopathy developed or worsened in 23 (15 percent) two to six months after treatment. The change was transient in 15 patients, but it persisted in 8 (5 percent), who subsequently required treatment for their eye disease. None of the 55 other patients in this group who had ophthalmopathy at base line had improvement in their eye disease. Among the 145 patients treated with radioiodine and prednisone, 50 (67 percent) of the 75 with ophthalmopathy at base line had improvement, and no patient had progression. The effects of radioio...Continue Reading

References

Jun 25, 1992·The New England Journal of Medicine·L TallstedtA Taube
Jan 1, 1992·Thyroid : Official Journal of the American Thyroid Association·C MarcocciA Pinchera
May 1, 1990·Archives of Internal Medicine·M F PrummelR van der Gaag
Jul 1, 1989·Lancet·H Vestergaard, P Laurberg
Sep 16, 1989·Lancet·F KarlssonP Enoksson
Nov 1, 1989·Journal of Endocrinological Investigation·L BartalenaA Pinchera
Jul 1, 1989·The American Journal of Medicine·V Sridama, L J DeGroot
Aug 1, 1989·The British Journal of Ophthalmology·M P MouritsR van der Gaag
Nov 1, 1973·The Journal of Clinical Endocrinology and Metabolism·R D WasnichJ P Kriss
Nov 1, 1995·European Journal of Endocrinology·L BartalenaE Martino
Feb 1, 1995·The Journal of Clinical Endocrinology and Metabolism·W Wiersinga, M F Prummel
Dec 1, 1993·Endocrine Reviews·H B Burch, L Wartofsky
Sep 1, 1993·The British Journal of Surgery·J R Fernández SánchezR Vara Thorbeck
Apr 1, 1996·American Journal of Ophthalmology·G B BartleyC A Gorman
Aug 1, 1996·Thyroid : Official Journal of the American Thyroid Association·L BartalenaE Martino
Jun 1, 1997·Thyroid : Official Journal of the American Thyroid Association·P VittiA Pinchera

❮ Previous
Next ❯

Citations

Jul 14, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Marcel P M StokkelMarkus Luster
Apr 16, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·I SterkerD Führer
May 19, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·K LaubnerJ Seufert
May 1, 2012·Pediatric Surgery International·Elena PeroniGiovanna Weber
Feb 23, 2012·Current Neurology and Neuroscience Reports·Erin F GillespieRaymond S Douglas
Apr 14, 2005·Best Practice & Research. Clinical Endocrinology & Metabolism·Takao AndoTerry F Davies
Nov 19, 2013·Journal français d'ophtalmologie·B LerayP Caron
Mar 4, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·M K Gupta
Mar 29, 2000·Survey of Ophthalmology·K C KubisJ R Bilyk
Aug 21, 2003·Lancet·David S Cooper
Jun 30, 2000·Endocrinology and Metabolism Clinics of North America·W M Wiersinga, M F Prummel
Aug 7, 2002·Trends in Endocrinology and Metabolism : TEM·Wilmar M Wiersinga, Mark F Prummel
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Domenico Salvatore, Gianfranco Fenzi
Apr 25, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Wilmar M Wiersinga
Jun 25, 2008·Nature Clinical Practice. Endocrinology & Metabolism·R A Ajjan, A P Weetman
Oct 16, 2013·Nature Reviews. Endocrinology·Luigi Bartalena
Dec 23, 1998·Clinical Endocrinology·N J Leech, C M Dayan
Feb 24, 2001·Clinical Endocrinology·M F PrummelW M Wiersinga
May 25, 2002·ANZ Journal of Surgery·Michael S BarakateLeigh W Delbridge
Feb 1, 2007·Seminars in Plastic Surgery·Adel H Alsuhaibani, Jeffrey A Nerad
Jan 8, 1998·The New England Journal of Medicine·W M Wiersinga
May 23, 1998·The New England Journal of Medicine·C A Gorman, K P Offord
Nov 9, 2000·The New England Journal of Medicine·A P Weetman
Jun 14, 2008·The New England Journal of Medicine·Gregory A Brent
Mar 7, 2009·The New England Journal of Medicine·Luigi Bartalena, Maria Laura Tanda
Feb 11, 2011·The New England Journal of Medicine·Douglas S Ross
Apr 6, 2001·Thyroid : Official Journal of the American Thyroid Association·M MarinòL Chiovato
Apr 6, 2001·Thyroid : Official Journal of the American Thyroid Association·P Werga-KjellmanG Wallin
Nov 22, 2001·Thyroid : Official Journal of the American Thyroid Association·S C JyonouchiR S Bahn
Apr 16, 2002·Thyroid : Official Journal of the American Thyroid Association·Marian E Ludgate
Apr 16, 2002·Thyroid : Official Journal of the American Thyroid Association·Petros Perros, Pat Kendall-Taylor
Jul 5, 2002·Thyroid : Official Journal of the American Thyroid Association·Simonetta LisiLuca Chiovato
Dec 19, 2002·Thyroid : Official Journal of the American Thyroid Association·Wilmar M Wiersinga, Luigi Bartalena
Sep 11, 2003·Thyroid : Official Journal of the American Thyroid Association·Mariacarla MoletiFrancesco Vermiglio
Nov 1, 2003·Thyroid : Official Journal of the American Thyroid Association·Michele MarinòLuca Chiovato
Oct 16, 2003·Thyroid : Official Journal of the American Thyroid Association·Daniel Chun-Hang WaiDaphne Hsu-Chin Khoo
Jan 27, 1999·Thyroid : Official Journal of the American Thyroid Association·C SpitzwegA E Heufelder
Jun 12, 1998·Thyroid : Official Journal of the American Thyroid Association·L E Braverman
Jul 21, 1998·Thyroid : Official Journal of the American Thyroid Association·L BartalenaA Pinchera
Mar 25, 1999·Thyroid : Official Journal of the American Thyroid Association·L A BurmeisterJ R Wall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.